(Q24805160)

PubMed

https://scigraph.springernature.com/pub.10.1186/1471-2377-3-7

26 October 2020

anti-inflammatory agent

1 reference

19 July 2021

1 reference

Craig Campbell

1

0 references

Pierre Jacob

series ordinal

2

0 references

language of work or name

English

0 references

publication date

8 September 2003

6 references

13 March 2019

22 April 2019

25 April 2019

13 November 2019

26 October 2020

19 July 2021

6 references

13 March 2019

22 April 2019

25 April 2019

13 November 2019

26 October 2020

19 July 2021

3

0 references

issue

1

0 references

page(s)

7

0 references

exact match

0 references

cites work

Randomized, controlled trials, observational studies, and the hierarchy of research designs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=222985

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=222985

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=222985

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=222985

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=222985

Pharmacologic and genetic therapy for childhood muscular dystrophies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=222985

Assessing the quality of randomized controlled trials. Current issues and future directions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=222985

Should unpublished data be included in meta-analyses? Current convictions and controversies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=222985

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=222985

Deflazacort treatment of Duchenne muscular dystrophy

28 September 2017

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-3-7

Blepharospasm in association with a lower pontine lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-3-7

Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-3-7

A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-3-7

Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-3-7

21 January 2018

The muscular dystrophies

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-3-7

A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-3-7

Deflazacort in Duchenne dystrophy: study of long-term effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-3-7

Steroids in duchenne muscular dystrophy — Deflazacort trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-3-7

Deflazacort vs. prednisone in Duchenne muscular dystrophy: trends of an ongoing study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-3-7

Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-3-7

[Steroid treatment of Duchenne's muscular dystrophy]

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12962544

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

47th ENMC International Workshop: Treatment of Muscular Dystrophy. 13-15 December 1996, Naarden, The Netherlands

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12962544

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2377-3-7

0 references

Dimensions Publication ID

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2377-3-7

release_wtijkh3frveyll5aegh662akba

9 September 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wtijkh3frveyll5aegh662akba